vs
Autonomix Medical, Inc.（AMIX）与泰利福（TFX）财务数据对比。点击上方公司名可切换其他公司
Autonomix Medical, Inc.自由现金流更多（$-3.0M vs $-92.9M）
Autonomix Medical是一家专注于心脏电生理领域的医疗科技企业，主要开发用于心律失常诊断与治疗的微创医疗设备，服务北美、欧洲地区的医疗机构与患者，致力于提升心律相关心脏疾病的诊疗效率与效果。
泰利福（Teleflex）总部位于美国宾夕法尼亚州韦恩，是专业医疗设备供应商，产品广泛应用于重症监护、外科手术等各类诊疗场景。公司年营收达24亿美元，在全球40个国家开展业务，员工总数超15000人。经过数年的收并购与业务剥离，公司于2011年完成业务调整，全面聚焦医疗设备制造领域。
AMIX vs TFX — 直观对比
营收规模更大
AMIX
是对方的0.0倍
$-401.9M
自由现金流更多
AMIX
多$90.0M
$-92.9M
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $0 | $-401.9M |
| 净利润 | $-3.3M | $-714.3M |
| 毛利率 | — | — |
| 营业利润率 | — | — |
| 净利率 | — | 177.8% |
| 营收同比 | — | -150.5% |
| 净利润同比 | -20.2% | -422.7% |
| 每股收益（稀释后） | — | $-15.85 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMIXTFX
| Q4 25 | $0 | $-401.9M | ||
| Q3 25 | $0 | $913.0M | ||
| Q2 25 | $0 | $780.9M | ||
| Q1 25 | $0 | $700.7M | ||
| Q4 24 | $0 | $795.4M | ||
| Q3 24 | $0 | $764.4M | ||
| Q2 24 | $0 | $749.7M | ||
| Q1 24 | — | $737.8M |
净利润AMIXTFX
| Q4 25 | $-3.3M | $-714.3M | ||
| Q3 25 | $-7.5M | $-408.9M | ||
| Q2 25 | $-3.3M | $122.6M | ||
| Q1 25 | $-3.2M | $95.0M | ||
| Q4 24 | $-2.7M | $-136.7M | ||
| Q3 24 | $-2.8M | $111.0M | ||
| Q2 24 | $-2.7M | $80.0M | ||
| Q1 24 | — | $15.3M |
毛利率AMIXTFX
| Q4 25 | — | — | ||
| Q3 25 | — | 49.5% | ||
| Q2 25 | — | 55.2% | ||
| Q1 25 | — | 55.6% | ||
| Q4 24 | — | 55.3% | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.6% | ||
| Q1 24 | — | 56.4% |
营业利润率AMIXTFX
| Q4 25 | — | — | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 17.9% | ||
| Q4 24 | — | -13.9% | ||
| Q3 24 | — | 19.5% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | -0.6% |
净利率AMIXTFX
| Q4 25 | — | 177.8% | ||
| Q3 25 | — | -44.8% | ||
| Q2 25 | — | 15.7% | ||
| Q1 25 | — | 13.6% | ||
| Q4 24 | — | -17.2% | ||
| Q3 24 | — | 14.5% | ||
| Q2 24 | — | 10.7% | ||
| Q1 24 | — | 2.1% |
每股收益（稀释后）AMIXTFX
| Q4 25 | — | $-15.85 | ||
| Q3 25 | — | $-9.24 | ||
| Q2 25 | — | $2.77 | ||
| Q1 25 | — | $2.07 | ||
| Q4 24 | — | $-2.89 | ||
| Q3 24 | — | $2.36 | ||
| Q2 24 | — | $1.69 | ||
| Q1 24 | — | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $9.9M | $378.6M |
| 总债务越低越好 | — | $2.6B |
| 股东权益账面价值 | $8.6M | $3.1B |
| 总资产 | $10.2M | $6.9B |
| 负债/权益比越低杠杆越低 | — | 0.85× |
8季度趋势，按日历期对齐
现金及短期投资AMIXTFX
| Q4 25 | $9.9M | $378.6M | ||
| Q3 25 | $7.5M | $354.0M | ||
| Q2 25 | $8.6M | $253.7M | ||
| Q1 25 | $9.1M | $284.1M | ||
| Q4 24 | $11.8M | $290.2M | ||
| Q3 24 | $5.2M | $243.2M | ||
| Q2 24 | $6.8M | $238.6M | ||
| Q1 24 | — | $237.4M |
总债务AMIXTFX
| Q4 25 | — | $2.6B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.9B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益AMIXTFX
| Q4 25 | $8.6M | $3.1B | ||
| Q3 25 | $6.4M | $3.8B | ||
| Q2 25 | $7.0M | $4.2B | ||
| Q1 25 | $8.1M | $4.1B | ||
| Q4 24 | $9.7M | $4.3B | ||
| Q3 24 | $3.0M | $4.5B | ||
| Q2 24 | $5.3M | $4.6B | ||
| Q1 24 | — | $4.5B |
总资产AMIXTFX
| Q4 25 | $10.2M | $6.9B | ||
| Q3 25 | $7.9M | $7.9B | ||
| Q2 25 | $9.0M | $7.4B | ||
| Q1 25 | $9.8M | $7.2B | ||
| Q4 24 | $12.0M | $7.1B | ||
| Q3 24 | $5.4M | $7.5B | ||
| Q2 24 | $7.1M | $7.4B | ||
| Q1 24 | — | $7.5B |
负债/权益比AMIXTFX
| Q4 25 | — | 0.85× | ||
| Q3 25 | — | 0.70× | ||
| Q2 25 | — | 0.45× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 0.39× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.0M | $-92.3M |
| 自由现金流经营现金流 - 资本支出 | $-3.0M | $-92.9M |
| 自由现金流率自由现金流/营收 | — | 23.1% |
| 资本支出强度资本支出/营收 | — | -0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $1.4M |
8季度趋势，按日历期对齐
经营现金流AMIXTFX
| Q4 25 | $-3.0M | $-92.3M | ||
| Q3 25 | $-3.8M | $107.8M | ||
| Q2 25 | $-2.6M | $7.8M | ||
| Q1 25 | $-2.6M | $73.3M | ||
| Q4 24 | $-2.3M | $202.6M | ||
| Q3 24 | $-1.6M | $231.1M | ||
| Q2 24 | $-1.9M | $91.7M | ||
| Q1 24 | — | $112.8M |
自由现金流AMIXTFX
| Q4 25 | $-3.0M | $-92.9M | ||
| Q3 25 | — | $77.8M | ||
| Q2 25 | — | $-26.8M | ||
| Q1 25 | — | $43.3M | ||
| Q4 24 | $-2.3M | $170.6M | ||
| Q3 24 | — | $209.9M | ||
| Q2 24 | $-1.9M | $56.9M | ||
| Q1 24 | — | $74.4M |
自由现金流率AMIXTFX
| Q4 25 | — | 23.1% | ||
| Q3 25 | — | 8.5% | ||
| Q2 25 | — | -3.4% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 21.4% | ||
| Q3 24 | — | 27.5% | ||
| Q2 24 | — | 7.6% | ||
| Q1 24 | — | 10.1% |
资本支出强度AMIXTFX
| Q4 25 | — | -0.2% | ||
| Q3 25 | — | 3.3% | ||
| Q2 25 | — | 4.4% | ||
| Q1 25 | — | 4.3% | ||
| Q4 24 | — | 4.0% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 5.2% |
现金转化率AMIXTFX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.08× | ||
| Q2 24 | — | 1.15× | ||
| Q1 24 | — | 7.38× |
